San Diego, CA, United States of America

Jia Xie

This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: Scripps Research Institute, Hesperix Sa, Zebra Biologies, Inc.. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jia Xie. Retrieved from https://idiyas.com/inventor/jia-xie-tj2sebo5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jia Xie

Introduction

Jia Xie is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of personalized medicine, particularly in cancer therapy. With a total of five patents to her name, she has made remarkable strides in utilizing advanced technologies to improve treatment outcomes for patients.

Latest Patents

Among her latest patents, Jia Xie has developed articles and methods directed to personalized therapy of cancer. These methods focus on providing personalized medicine for the treatment of B cell malignancies, including lymphoma. Notably, her work makes use of Chimeric Antigen Receptor (CAR) technology, which has the potential to revolutionize cancer treatment by tailoring therapies to individual patient needs.

Career Highlights

Throughout her career, Jia Xie has worked with esteemed organizations such as The Scripps Research Institute and Hesperix SA. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in cancer therapy.

Collaborations

Some of her notable coworkers include Richard A. Lerner and Alexey Vyacheslavovich Stepanov. Their collaborative efforts have further advanced the research and development of innovative cancer treatments.

Conclusion

Jia Xie's work exemplifies the impact of innovation in the medical field, particularly in the realm of personalized cancer therapy. Her contributions continue to pave the way for more effective treatment options for patients facing B cell malignancies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…